Chinese Journal of Cancer Research

Papers
(The median citation count of Chinese Journal of Cancer Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Esophageal cancer: Epidemiology, risk factors and screening61
Screening for gastric cancer in China: Advances, challenges and visions46
Colorectal cancer burden and trends: Comparison between China and major burden countries in the world42
Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study38
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)30
Update in version 2021 of CSCO guidelines for colorectal cancer from version 202024
Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−203021
Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review19
CSCO guidelines for colorectal cancer version 2022: Updates and discussions19
Mn-based cGAS-STING activation for tumor therapy18
Surgical treatment of gastric cancer: Current status and future directions15
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)13
Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing13
Burden of liver cancer: From epidemiology to prevention13
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)12
Lung cancer risk in never-smokers: An overview of environmental and genetic factors12
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression12
Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 201811
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)11
Current status of lymph node dissection in gastric cancer11
Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer10
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns10
Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics9
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma9
Prognostic value of a modified Immunosocre in patients with stage I−III resectable colon cancer9
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial8
Attributable deaths of liver cancer in China8
Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer8
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer8
Inducing immunogenic cell death in immuno-oncological therapies8
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)8
A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy7
Open surgery in the era of minimally invasive surgery7
Laparoscopic vs. open surgery for gastrointestinal stromal tumors of esophagogastric junction: A multicenter, retrospective cohort analysis with propensity score weighting7
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)7
Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis7
Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008−20177
Current status and future perspectives on neoadjuvant therapy in gastric cancer7
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts7
Mitochondrial malic enzyme 2 promotes breast cancer metastasis via stabilizing HIF-1α under hypoxia6
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)6
Development and validation of a CT-based radiomics nomogram for preoperative prediction of tumor histologic grade in gastric adenocarcinoma6
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small cell lung cancer: A real-world, multicenter, retrospective, controlled study in China6
ZNF292 suppresses proliferation of ESCC cells through ZNF292/SKP2/P27 signaling axis6
Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress6
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)6
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road6
Current status and perspectives of conversion therapy for advanced gastric cancer6
Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer5
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update5
Deregulated expression and subcellular localization of CPSF6, a circRNA-binding protein, promote malignant development of esophageal squamous cell carcinoma5
Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trial5
Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis5
Single-cell DNA methylome analysis of circulating tumor cells5
Validation and modification of the AJCC 8th TNM staging system for pancreatic ductal adenocarcinoma in a Chinese cohort: A nationwide pancreas data center analysis4
Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China4
Deep learning model improves radiologists’ performance in detection and classification of breast lesions4
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma4
Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)4
A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma4
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphoma4
Recent updates and current issues of sentinel node navigation surgery for early gastric cancer4
Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?4
Stomach cancer burden in China: Epidemiology and prevention4
Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis4
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)4
Pain threshold, anxiety and other factors affect intensity of postoperative pain in gastric cancer patients: A prospective cohort study4
Novel technologies in cfDNA analysis and potential utility in clinic3
Effect of preoperative nutrition therapy type and duration on short-time outcomes in gastric cancer patient with gastric outlet obstruction3
Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials3
Genomic landscape of T-cell lymphoblastic lymphoma3
Vorolanib, an oral VEGFR/PDGFR dual tyrosine kinase inhibitor for treatment of patients with advanced solid tumors: An open-label, phase I dose escalation and dose expansion trial3
Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma3
Laparoscopic surgery for gastric cancer: Current status and future direction3
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma3
Research advances of secretory proteins in malignant tumors3
All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma3
Identification of lymph node metastasis by computed tomography in early gastric cancer3
Current status and challenges in sentinel node navigation surgery for early gastric cancer2
Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment2
Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer2
Psychosomatic symptoms affect radiotherapy setup errors in early breast cancer patients2
A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers2
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics2
Corrigendum to Tumor-associated macrophages regulate gastric cancer cell invasion and metastasis through TGFβ2/NF-κB/Kindlin-2 axis2
Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)2
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations2
Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts2
Intraperitoneal chemotherapy for gastric cancer: A contemporary perspective2
Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer2
0.037636995315552